Literature DB >> 34079707

Multi-channel multi-task deep learning for predicting EGFR and KRAS mutations of non-small cell lung cancer on CT images.

Yunyun Dong1,2, Lina Hou3, Wenkai Yang2, Jiahao Han2, Jiawen Wang2, Yan Qiang2, Juanjuan Zhao2, Jiaxin Hou2, Kai Song2, Yulan Ma2, Ntikurako Guy Fernand Kazihise2, Yanfen Cui3, Xiaotang Yang3.   

Abstract

BACKGROUND: Predicting the mutation statuses of 2 essential pathogenic genes [epidermal growth factor receptor (EGFR) and Kirsten rat sarcoma (KRAS)] in non-small cell lung cancer (NSCLC) based on CT is valuable for targeted therapy because it is a non-invasive and less costly method. Although deep learning technology has realized substantial computer vision achievements, CT imaging being used to predict gene mutations remains challenging due to small dataset limitations.
METHODS: We propose a multi-channel and multi-task deep learning (MMDL) model for the simultaneous prediction of EGFR and KRAS mutation statuses based on CT images. First, we decomposed each 3D lung nodule into 9 views. Then, we used the pre-trained inception-attention-resnet model for each view to learn the features of the nodules. By combining 9 inception-attention-resnet models to predict the types of gene mutations in lung nodules, the models were adaptively weighted, and the proposed MMDL model could be trained end-to-end. The MMDL model utilized multiple channels to characterize the nodule more comprehensively and integrate patient personal information into our learning process.
RESULTS: We trained the proposed MMDL model using a dataset of 363 patients collected by our partner hospital and conducted a multi-center validation on 162 patients in The Cancer Imaging Archive (TCIA) public dataset. The accuracies for the prediction of EGFR and KRAS mutations were, respectively, 79.43% and 72.25% in the training dataset and 75.06% and 69.64% in the validation dataset.
CONCLUSIONS: The experimental results demonstrated that the proposed MMDL model outperformed the latest methods in predicting EGFR and KRAS mutations in NSCLC. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Deep learning; Kirsten rat sarcoma (KRAS); computed tomography (CT); epidermal growth factor receptor (EGFR); non-small cell lung cancer (NSCLC)

Year:  2021        PMID: 34079707      PMCID: PMC8107307          DOI: 10.21037/qims-20-600

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  34 in total

Review 1.  Deep learning.

Authors:  Yann LeCun; Yoshua Bengio; Geoffrey Hinton
Journal:  Nature       Date:  2015-05-28       Impact factor: 49.962

2.  Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas.

Authors:  Ying Liu; Jongphil Kim; Yoganand Balagurunathan; Qian Li; Alberto L Garcia; Olya Stringfield; Zhaoxiang Ye; Robert J Gillies
Journal:  Clin Lung Cancer       Date:  2016-02-16       Impact factor: 4.785

3.  Dermatologist-level classification of skin cancer with deep neural networks.

Authors:  Andre Esteva; Brett Kuprel; Roberto A Novoa; Justin Ko; Susan M Swetter; Helen M Blau; Sebastian Thrun
Journal:  Nature       Date:  2017-01-25       Impact factor: 49.962

4.  Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer.

Authors:  Emmanuel Rios Velazquez; Chintan Parmar; Ying Liu; Thibaud P Coroller; Gisele Cruz; Olya Stringfield; Zhaoxiang Ye; Mike Makrigiorgos; Fiona Fennessy; Raymond H Mak; Robert Gillies; John Quackenbush; Hugo J W L Aerts
Journal:  Cancer Res       Date:  2017-05-31       Impact factor: 12.701

5.  Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.

Authors:  Scott J Antonia; Augusto Villegas; Davey Daniel; David Vicente; Shuji Murakami; Rina Hui; Takayasu Kurata; Alberto Chiappori; Ki H Lee; Maike de Wit; Byoung C Cho; Maryam Bourhaba; Xavier Quantin; Takaaki Tokito; Tarek Mekhail; David Planchard; Young-Chul Kim; Christos S Karapetis; Sandrine Hiret; Gyula Ostoros; Kaoru Kubota; Jhanelle E Gray; Luis Paz-Ares; Javier de Castro Carpeño; Corinne Faivre-Finn; Martin Reck; Johan Vansteenkiste; David R Spigel; Catherine Wadsworth; Giovanni Melillo; Maria Taboada; Phillip A Dennis; Mustafa Özgüroğlu
Journal:  N Engl J Med       Date:  2018-09-25       Impact factor: 91.245

6.  Prognostic value of epidermal growth factor receptor mutations and histologic subtypes with lung adenocarcinoma.

Authors:  Nozomu Motono; Aika Funasaki; Atsushi Sekimura; Katsuo Usuda; Hidetaka Uramoto
Journal:  Med Oncol       Date:  2018-01-31       Impact factor: 3.064

7.  Deep Convolutional Neural Networks for Computer-Aided Detection: CNN Architectures, Dataset Characteristics and Transfer Learning.

Authors:  Hoo-Chang Shin; Holger R Roth; Mingchen Gao; Le Lu; Ziyue Xu; Isabella Nogues; Jianhua Yao; Daniel Mollura; Ronald M Summers
Journal:  IEEE Trans Med Imaging       Date:  2016-02-11       Impact factor: 10.048

Review 8.  Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literature.

Authors:  Bradford J Siegele; Konstantin Shilo; Bo H Chao; David P Carbone; Weiqiang Zhao; Olga Ioffe; Wilbur A Franklin; Martin J Edelman; Dara L Aisner
Journal:  Lung Cancer       Date:  2016-02-26       Impact factor: 5.705

9.  EGFR mutations are associated with higher incidence of distant metastases and smaller tumor size in patients with non-small-cell lung cancer based on PET/CT scan.

Authors:  Jian Guan; Min Chen; Nanjie Xiao; Lu Li; Yue Zhang; Qinyang Li; Mi Yang; Laiyu Liu; Longhua Chen
Journal:  Med Oncol       Date:  2015-11-20       Impact factor: 3.064

10.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.

Authors:  Hugo J W L Aerts; Emmanuel Rios Velazquez; Ralph T H Leijenaar; Chintan Parmar; Patrick Grossmann; Sara Carvalho; Sara Cavalho; Johan Bussink; René Monshouwer; Benjamin Haibe-Kains; Derek Rietveld; Frank Hoebers; Michelle M Rietbergen; C René Leemans; Andre Dekker; John Quackenbush; Robert J Gillies; Philippe Lambin
Journal:  Nat Commun       Date:  2014-06-03       Impact factor: 14.919

View more
  2 in total

1.  Artificial Intelligence-Assisted Score Analysis for Predicting the Expression of the Immunotherapy Biomarker PD-L1 in Lung Cancer.

Authors:  Guoping Cheng; Fuchuang Zhang; Yishi Xing; Xingyi Hu; He Zhang; Shiting Chen; Mengdao Li; Chaolong Peng; Guangtai Ding; Dadong Zhang; Peilin Chen; Qingxin Xia; Meijuan Wu
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

2.  Deep Radiotranscriptomics of Non-Small Cell Lung Carcinoma for Assessing Molecular and Histology Subtypes with a Data-Driven Analysis.

Authors:  Eleftherios Trivizakis; John Souglakos; Apostolos Karantanas; Kostas Marias
Journal:  Diagnostics (Basel)       Date:  2021-12-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.